FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

By FDA, USA

 

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia.

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

The FDA granted the approval of Besponsa to Pfizer Inc.

 

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm572131.htm

More from tokioX :

  1. FDA approves gene therapy Luxturna for hereditary blindness
  2. 💊FDA PHARMA today
  3. 💊Press Announcements > FDA announces approval,
  4. 💊the U.S. Food and Drug Administration has approved
  5. 💊FDA approves pill with sensor that digitally tracks if patients have ingested their medication.
  6. 💊FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer. 〜 Hoffman-LaRoche, Inc.
  7. MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid Leukemia Therapies